Craft

Enliven Therapeutics

Stock Price

$28.5

2024-10-29

Market Capitalization

$1.3 B

2024-10-29

Enliven Therapeutics Summary

Company Summary

Overview
Enliven Therapeutics is a biopharmaceutical company that specializes in cancer treatment solutions. It focuses on discovering and developing small-molecule kinase inhibitor therapies to treat cancer.
Type
Public
Status
Active
Founded
2019
Website
https://www.enliventherapeutics.com
Cybersecurity rating
Sectors

Table of Contents

Footer menu